Bacteria possess an array of defenses against foreign invaders, including diverse nucleases that target and destroy the genome of an invading bacteriophage or foreign DNA element. A recently-described bacteriophage immunity pathway employs a cGAS/DncV-like nucleotidyltransferase to produce a cyclic tri-AMP second messenger, which activates the DNA endonuclease effector NucC. Here, we show that NucC is related to restriction enzymes but uniquely assembles into a homotrimer in solution. cAAA binding in a conserved allosteric pocket promotes assembly of two NucC trimers into a homohexamer competent for doublestrand DNA cleavage. We propose that NucC mediates bacteriophage immunity either through global activation, causing altruistic cell death and abortive infection, or through local activation and targeted phage genome destruction. Finally, we identify NucC homologs in type III CRISPR-Cas systems, where they likely function as accessory nucleases activated by cyclic oligoadenylate second messengers synthesized by these systems' effector complexes.
Introduction
Bacteria are locked in a continual struggle to protect themselves and their genomes from foreign mobile genetic elements and bacteriophages, and as such have evolved sophisticated defenses against these invaders. Two well-characterized bacterial defense systems are restriction-modification systems and CRISPR-Cas systems, both of which rely on targeted nuclease activity to destroy foreign nucleic acids. In a typical restrictionmodification system, a bacterium encodes a sequence-specific DNA endonuclease, and a corresponding DNA methylase that modifies the host genome to protect it against endonuclease cleavage (Arber and Linn, 1969; Wilson and Murray, 1991) . While restriction-modification systems mount a standard response to all improperly modified DNA and as such can be likened to an "innate" immune system, the more recentlycharacterized CRISPR-Cas systems are more akin to an "adaptive" immune system. In these systems, effector nucleases are loaded with guide sequences that specifically target foreign nucleic acids Sorek et al., 2013; Wright et al., 2016) . In type III CRISPR-Cas systems, the multi-protein effector complex not only recognizes and cleave foreign RNA and DNA Pyenson and Marraffini, 2017) , but also synthesizes 3¢-5¢ linked cyclic oligoadenylate second messengers upon target binding (Kazlauskiene et al., 2017; Niewoehner et al., 2017) . These second messengers in turn activate accessory RNases encoded in the same operons, including Csm6 (type IIIA systems) and Csx1 (type IIIB) (Han et al., 2018; Kazlauskiene et al., 2017; Niewoehner et al., 2017) .
We recently characterized a newly-described bacterial defense pathway encoding a cGAS/DncV-like nucleotidyltransferase (CD-NTase) plus regulator proteins related to eukaryotic HORMA domain proteins and the AAA+ ATPase Pch2/TRIP13 (Ye et al., 2019) . Our findings support a model in which detection of specific foreign peptides by bacterial HORMA domain proteins stimulates synthesis of a nucleotide second messenger, which activates one of several classes of effector proteins (Burroughs et al., 2015; Ye et al., 2019) . We characterized two operons from patient-derived strains of E. coli and Pseudomonas aeruginosa whose CD-NTases synthesize the cyclic trinucleotide second messenger cyclic AMP-AMP-AMP (cAAA). Both operons also encode a restriction endonuclease-related effector protein termed NucC (Nuclease, CD-NTase associated), which is activated by cAAA and required for bacteriophage immunity (Ye et al., 2019) . How a restriction endonuclease-related enzyme can be controlled by second messenger binding, however, remains an important unanswered question.
Here, we show that NucC is a homotrimeric DNA endonuclease that binds the second messenger cAAA in a three-fold symmetric allosteric pocket. We show that nuclease activation involves the assembly of two NucC trimers into a homohexamer, which juxtaposes pairs of endonuclease active sites and promotes coordinated double-strand DNA cleavage. NucC is largely sequence non-specific and is not inhibited by DNA methylation, suggesting that high-level activation in cells may cause genome destruction and cell death. Finally, we identify type III CRISPR operons that encode NucC homologs in place of the accessory RNases Csm6/Csx1, defining a new family of type III CRISPR systems encoding a cyclic oligoadenylate-activated accessory DNase.
Results

Bacterial CD-NTase associated nucleases adopt a homotrimeric architecture
We have recently shown that a bacterial CD-NTase-encoding operon from a patient-derived strain of E. coli (MS115-1) provides immunity against bacteriophage infection, likely acting by sensing one or more phage proteins and synthesizing cAAA in response (Ye et al., 2019) . The putative effector protein in this operon, which we term NucC (Nuclease, CD-NTase-associated), is a cAAA-activated DNA endonuclease necessary for phage immunity (Ye et al., 2019) . To understand the structure of NucC and its mechanism of activation, we overexpressed and purified E. coli MS115-1 (Ec) NucC, and a second NucC from a related operon found in Pseudomonas aeruginosa strain ATCC27853 (Pa) (Fig.  1A) . Both Ec NucC and Pa NucC self-associate in yeast two-hybrid assays (Ye et al., 2019) , and we used size exclusion chromatography coupled to multi-angle light scattering (SEC-MALS) to show that both proteins form homotrimers in solution ( Fig. S1A-B ). While several families of DNA exonucleases -including bacteriophage l nuclease (Kovall and Matthews, 1997; Zhang et al., 2011) and the archaeal nuclease PhoExoI (Miyazono et al., 2015) -are known to form homotrimers, endonucleases are more commonly homodimeric, with two active sites that cleave opposite DNA strands to effect double-strand cleavage (Pingoud et al., 2005) .
We crystallized and determined the structure of Ec NucC to a resolution of 1.75 Å (Table S1 ). In agreement with prior sequence analysis (Burroughs et al., 2015) , the NucC monomer adopts a restriction endonuclease fold ( Fig. 1B) . A database search using the DALI structurecomparison server (Holm and Rosenström, 2010) revealed that NucC is structurally related to type II restriction endonucleases, including NgoMIV (Deibert et al., 2000) , Kpn2I (PDB ID 6EKR; unpublished), and SgrAI . Indeed, comparing NucC with a structure of SgrAI bound to DNA reveals an overall r.m.s.d. of 1.97 Å over 132 aligned Ca atoms ( Fig. 1B and S1C-D) . NucC also possesses a conserved active site motif of IDx30EAK (residues 72-106 in Ec NucC), with the conserved acidic residues Asp73 and Glu104 coordinating a Mg 2+ ion in our structure (Fig. 1C) . Mutation of Asp73 to Asn disrupts the endonuclease activity of NucC, demonstrating that DNA cleavage likely occurs through an equivalent mechanism as type II restriction endonucleases ( Fig. 1D) . We previously showed that the same mutation disrupts the ability of the E. coli MS115-1 CD-NTase operon to confer immunity against bacteriophage infection (Ye et al., 2019) . Consistent with our SEC-MALS data, the structure of NucC reveals a tightly-packed homotrimer with an overall triangular architecture (Fig. 1C) . The three active sites are arrayed on the outer edge of the trimer. The trimer interface of NucC is composed largely of elements that are not part of the core nuclease fold, but are rather embellishments not shared with dimeric restriction endonucleases ( Fig.  S1E ).
NucC binds cAAA in an allosteric pocket
We next tested binding of NucC to a range of dinucleotide and trinucleotide ( Fig. S2 ) second messengers using isothermal titration calorimetry (ITC). We found that Ec NucC binds strongly to 3¢,3¢,3¢ cAAA (Kd = 0.7 µM), binds more weakly to both 3¢,3¢ cyclic di-AMP (Kd = 2.6 µM) and linear di-AMP (5¢-pApA; 4.4 µM), and does not bind 2¢,3¢ cyclic di-AMP or AMP ( Fig. S3) . No second messenger bound with a stoichiometry higher than ~0.3 molecules per NucC monomer in our ITC assays, suggesting that the NucC trimer likely possesses a single second messenger binding site.
We next co-crystallized Ec NucC with 3¢,3¢,3¢ cAAA and determined the structure of the complex to a resolution of 1.66 Å ( Table S1 ). The structure reveals that a single cAAA molecule binds in a conserved, three-fold symmetric allosteric pocket on the "bottom" of the NucC trimer ( Fig. 2A) . Each adenine base is recognized through a hydrogen bond between its C6 amine group and the main-chain carbonyl of Val227, and through p-stacking with Tyr81 ( Fig. 2B-C) . In addition, NucC residues Arg53 and Thr226 form a hydrogen-bond network with each phosphate group of the cyclic trinucleotide ( Fig. 2B) . Binding of cAAA induces a dramatic conformational change in an extended hairpin loop in NucC, which we term the "gate loop", resulting in the closure of all three loops over the conserved pocket to completely enclose the bound cAAA molecule ( Fig. 2D) . Two aromatic residues, His136 and Tyr141, interact through p-stacking to stabilize the gate loop's structure in both bound and unbound states. In the cAAA-bound structure, these two residues serve to "latch" the gate loops through tight association at the three-fold axis of the NucC trimer. Mutation of gate loop residues His136 or Tyr141, or cAAA-binding residues Arg53, Tyr81, or Thr226 completely disrupts NucC's cAAA-activated endonuclease activity ( Fig. 2F) .
cAAA-mediated NucC hexamerization activates double-strand DNA cleavage
In the crystals of cAAA-bound Ec NucC, two NucC trimers associate to form a homohexamer through association of their a0 helices ( Fig. 2A) . This binding causes residues 23-34 linking a0 and a1, which are disordered in our NucC Apo structure and border the NucC active site, to become well-ordered in the cAAA-bound structure. We used SEC-MALS to confirm that both Ec NucC and Pa NucC form hexamers in solution when incubated with cAAA ( Fig. 2E and Fig. S4 ). These data suggest that cAAA activates NucC's nuclease activity in part by stimulating the formation of a NucC homohexamer.
We next modelled DNA binding by overlaying the NucC monomer with a structure of DNA-bound SgrAI . Hexamer formation juxtaposes pairs of NucC active sites from opposite trimers ~25 Å apart (Fig. 3A) , and we could model a continuous bent DNA duplex that contacts a pair of juxtaposed NucC active sites (Fig. 3B ). In this model, the putative scissile phosphate groups are positioned two base pairs apart on opposite DNA strands ( Fig. 3B) , such that coordinated cleavage at these two sites would yield a double-strand break with a twobase 3¢ overhang.
To determine whether NucC generates single-or double-strand breaks, we used limiting Mg 2+ conditions to enrich for singly-cut plasmid in a plasmid digestion assay ( Fig. 3C) . While NucC did generate a nicked species in this assay, we also observed a significant fraction of linear DNA that could only arise through cleavage of both DNA strands at a single site. To further support the idea that NucC can generate doublestrand breaks, we next completely digested a plasmid with NucC and deep-sequenced the resulting short fragments. To avoid losing information about DNA ends by "blunting" during sequencing library preparation, we denatured the fragments and sequenced individual DNA strands (see Materials and Methods). We thereby mapped ~1 million cleavage events, enabling us to assemble a picture of any preferred sequence motifs at NucC cleavage sites. We observed a striking two-fold symmetry in the preferred cleavage sites, with a strong preference for "T" at the 5¢ end (+1 base) of the cleaved fragment, and an equally strong preference for "A" at the −3 position ( Fig. 3D) . Similarly, we observed a weak preference for "G" at the +5 and +6 bases, and for "C" at the −7 and −8 bases. The two-fold symmetry of preferred NucC cleavage sites strongly suggests that two NucC active sites cooperate to cleave both strands of DNA. Moreover, the location of the breaks on each strand (as judged by the first sequenced base of the fragments) suggests that doublestranded cleavage by NucC results in two-base 3¢ overhangs, consistent with our structural modeling ( Fig. 3D and Fig. 3F ).
We used the same sequencing dataset to precisely measure the length distribution of NucC products. NucC product sizes followed a roughly Gaussian distribution with a mean of ~44 bases, in agreement with our electrophoretic results ( Fig. 3E) . Curiously, the size distribution showed a systematic variation from a Gaussian distribution, with slight enrichment of product lengths around 22, 44, and 66 base pairs in length. These data suggest that in addition to coordinated DNA cleavage by pairs of NucC active sites, cleavage by the three pairs of active sites in a NucC hexamer may be weakly coordinated, perhaps through wrapping of a single DNA around the complex to contact multiple sets of active sites.
Type III CRISPR systems encode NucC homologs
While exploring the distribution of NucC homologs in bacteria, we identified a group of NucC homologs with ~50% sequence identity to Ec NucC and Pa NucC, that are encoded not within CD-NTase operons but rather within type III CRISPR systems ( Fig. 4A-C) . Type III CRISPR systems encode a multi-subunit effector complex, that when activated by target binding synthesizes a range of cyclic oligoadenylate second messengers with 2-6 bases (cA2-cA6) (Kazlauskiene et al., 2017; Niewoehner et al., 2017) . These second messengers have been shown to activate accessory RNases in the CRISPR operons, with Csm6 activated by cA6 and Csx1 activated by cA4 (Han et al., 2018; Kazlauskiene et al., 2017; Niewoehner et al., 2017) . The presence of NucC homologs in type III CRISPR systems suggests that these enzymes may function similarly to their relatives in CD-NTase operons, with activation dependent on cAAA/cA3 synthesized by the CRISPR effector complexes.
We cloned several CRISPR-associated NucC proteins, and successfully purified one such enzyme from Vibrio metoecus, a close relative of V. cholerae (Kirchberger et al., 2014) . We found that V. metoecus NucC is a DNA endonuclease that is strongly activated by cAAA, and weakly activated by both cAA and cAAG, mirroring our findings with Ec NucC (Fig. 4D) (Ye et al., 2019) . By SEC-MALS, we found that V. metoecus NucC forms a mix of trimers and hexamers on its own, and forms solely hexamers after pre-incubation with cAAA ( Fig. 4E) . These data strongly support the idea that CRISPR-associated NucC homologs share a common activation and DNA cleavage mechanism with their relatives in CD-NTase operons. Thus, NucC homologs have been incorporated into type III CRISPR systems, where they are likely activated upon target recognition and cAAA synthesis by these systems' effector complexes.
Discussion
Bacteria possess an extraordinary variety of pathways to defend themselves against foreign threats including bacteriophages, invasive DNA elements like plasmids, and other bacteria. A large class of defense pathways, including classical restriction-modification systems and CRISPR-Cas systems, specifically defend the bacterial genome through the targeted action of DNA and RNA nucleases. Here, we describe the structure and mechanism of a restriction endonuclease-like protein, NucC, that is activated by a cyclic trinucleotide second messenger, cAAA. We have recently shown that the intact NucC-containing operon from a patient-derived E. coli strain confers immunity to bacteriophage l infection, and that both cAAA synthesis by this operon's CD-NTase and the DNA cleavage activity of NucC are required for immunity (Ye et al., 2019) . Thus, NucC is part of a widespread bacterial defense pathway that senses and responds to foreign threats including bacteriophages.
While evolutionarily related to restriction endonucleases, NucC adopts a unique homotrimeric structure with an allosteric binding pocket for its cyclic trinucleotide activator. This pocket is assembled from embellishments to the core nuclease fold, which include a "gate loop" that closes over the bound second messenger. cAAA binding stimulates assembly of two NucC trimers into a hexamer, juxtaposing pairs of active sites and activating double-strand DNA cleavage. While the nuclease does possess weak sequence preference, it is largely nonspecific and cleaves DNA to an average length of ~50 base pairs. NucC is apparently insensitive to DNA methylation (Ye et al., 2019) , meaning the bacterial genome may not be protected from NucC cleavage. Thus, we propose that CD-NTase operons encoding NucC may function as "abortive infection" pathways, in which an infected cell commits suicide to avoid producing more bacteriophage. Alternatively, localized activation of NucC within an infected cell may result in specific phage genome destruction.
Bacterial operons encoding CD-NTases are widespread among environmental and pathogenic bacteria, but are sparsely distributed and often associated with transposase or integrase genes and/or conjugation systems, suggesting that they are mobile DNA elements that likely confer some selective advantage on their bacterial host (Burroughs et al., 2015; . These operons encode diverse putative effector proteins including proteases, exonucleases, and two families of putative DNA endonucleases (Burroughs et al., 2015) . Given the structure of these operons, it is likely that these effectors are specifically activated by the second messenger synthesized by their associated CD-NTase . Bacterial CD-NTases have been classified into eight major clades, and while members of several clades have been shown to synthesize specific cyclic di-and trinucleotides , the full spectrum of products synthesized by these enzymes remains an important question. Given our data on NucC structure and activation, we propose that all bacterial CD-NTases associated with NucC -which includes members of clades C01 (including E. coli MS115-1 CdnC), C03, and D05 (including P. aeruginosa ATCC27853 CdnD) ) -likely synthesize cAAA. While CD-NTases in clades C01 and C03 are primarily associated with NucC effectors, clade D05 CD-NTases are associated with a range of effectors . One key question is whether all of these effectors are activated by cAAA, or whether their associated CD-NTases synthesize distinct second messengers. More broadly, a full accounting of bacterial CD-NTase products, and of the effector proteins they activate, remains an important area for future study.
While NucC is primarily found within CD-NTase operons, we also identify a group of type III CRISPR-Cas systems that encode homologs of NucC. Type III CRISPR systems uniquely encode nonspecific accessory RNases, Csm6 and Csx1, that are activated by cyclic oligoadenylates synthesized by their effector complexes (Han et al., 2018; Kazlauskiene et al., 2017; Niewoehner et al., 2017) . We show that at least one type III CRISPR-associated NucC homolog from Vibrio metoecus is a cAAA-stimulated DNA endonuclease that forms hexamers in the presence of cAAA. Thus, the production of a range of cyclic oligoadenylates including cAAA by type III CRISPR effector complexes has allowed NucC to be integrated into these systems as a tightly-controlled accessory nuclease. Given the high probability that other CD-NTase associated effectors are activated by cyclic oligoadenylates, it is possible that additional cases of such integration remain to be identified.
Materials and Methods
Protein Expression, Purification, and Characterization
Full length NucC genes from E. coli MS115-1 (synthesized by Invitrogen/Geneart), P. aeruginosa ATCC 27853 (amplified from genomic DNA), Vibrio metoecus sp. RC341 (synthesized by Invitrogen/Geneart), and Gynuella sunshinyii YC6258 (synthesized by Invitrogen/Geneart) were cloned into UC Berkeley Macrolab vector 1B (Addgene #29653) to generate N-terminal fusions to a TEV proteasecleavable His6-tag. Mutants of Ec NucC were generated by PCR mutagenesis.
Proteins were expressed in E. coli strain Rosetta2 pLysS (EMD Millipore) by induction with 0.25 mM IPTG at 20°C for 16 hours. For selenomethionine derivatization of Ec NucC, cells were grown in M9 minimal medium, then supplemented with amino acids (Leu, Ile and Val (50 mg/L), Phe, Lys, Thr (100 mg/L) and Selenomethionine (60 mg/L)) upon induction with IPTG.
For protein purification, cells were harvested by centrifugation, suspended in resuspension buffer (20 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole, 1 mM dithiothreitol (DTT) and 10% glycerol) and lysed by sonication. Lysates were clarified by centrifugation (16,000 rpm 30 min), then supernatant was loaded onto a Ni 2+ affinity column (HisTrap HP, GE Life Sciences) pre-equilibrated with resuspension buffer. The column was washed with buffer containing 20 mM imidazole and 100 mM NaCl, and eluted with a buffer containing 250 mM imidazole and 100 mM NaCl. The elution was loaded onto an anionexchange column (Hitrap Q HP, GE Life Sciences) and eluted using a 100-600 mM NaCl gradient. Fractions containing the protein were pooled and mixed with TEV protease (1:20 protease:NucC by weight) plus an additional 100 mM NaCl, then incubated 16 hours at 4°C for tag cleavage. Cleavage reactions were passed over a Ni 2+ affinity column, and the flow-through containing cleaved protein was collected and concentrated to 2 mL by ultrafiltration (Amicon Ultra-15, EMD Millipore), then passed over a size exclusion column (HiLoad Superdex 200 PG, GE Life Sciences) in a buffer containing 20 mM Tris-HCl pH 8.0, 300 mM NaCl, and 1 mM DTT. Purified proteins were concentrated by ultrafiltration and stored at 4°C for crystallization, or aliquoted and frozen at -80°C for biochemical assays. All mutant proteins were purified as wild-type.
For characterization of oligomeric state by size exclusion chromatography coupled to multi-angle light scattering (SEC-MALS), 100 µL of purified protein/complex at 2-5 mg/mL was injected onto a Superdex 200 Increase 10/300 GL column (GE Life Sciences) in a buffer containing 20 mM HEPES-NaOH pH 7.5, 300 mM NaCl, 5% glycerol, and 1 mM DTT. Light scattering and refractive index profiles were collected by miniDAWN TREOS and Optilab T-rEX detectors (Wyatt Technology), respectively, and molecular weight was calculated using ASTRA v. 6 software (Wyatt Technology).
Second messenger molecules
Cyclic and linear dinucleotides, including 5¢-pApA, 3¢,3¢-cGAMP, and 3¢,3¢-cyclic di-AMP, were purchased from Invivogen. Cyclic trinucleotides were generated enzymatically by Ec-CdnD02 from Enterobacter cloacae, which was cloned and purified as described . Briefly, a 40 mL synthesis reaction contained 500 nM Ec-CdnD02 and 0.25 mM each ATP and GTP (ATP alone for largescale synthesis of cAAA) in reaction buffer with 12.5 mM NaCl, 20 mM MgCl2, 1 mM DTT, and 10 mM Tris-HCl pH 9.0. The reaction was incubated at 37°C for 16 hours, then 2.5 units/mL reaction volume (100 units for 40 mL reaction) calf intestinal phosphatase was added and the reaction incubated a further 4 hours at 37°C. The reaction was heated to 65°C for 30 minutes, and centrifuged 20 minutes at 4,000 RPM to remove precipitated protein. Reaction products were separated by ion-exchange chromatography (Mono-Q, GE Life Sciences) using a gradient from 0 to 2 M ammonium acetate. Three major product peaks (Fig. S2A) were pooled, evaporated using a speedvac, then resuspended in water and analyzed by LC MS/MS. cAAA synthesized by the E. coli MS115-1 CdnC:HORMA complex was similarly purified and verified to activate NucC equivalently to that synthesized by Ec-CdnD02 (Ye et al., 2019) .
Mass spectrometry
Whiteley et al. previously identified the major product of Ec-CdnD02 as cAAG by NMR . To further characterize the products of Ec-CdnD02, we performed liquid chromatography-tandem mass spectrometry (LC-MS/MS) ( Fig. S2B-D) . LC-MS/MS analysis was performed using a Thermo Scientific Vanquish UHPLC coupled to a Thermo Scientific Q Exactive™ HF Hybrid Quadrupole-Orbitrap™ Mass Spectrometer, utilizing a ZIC-pHILIC polymeric column (100 mm x 2.1 mm, 5 μm) (EMD Millipore) maintained at 45 °C and flowing at 0.4 mL/min. Separation of cyclic trinucleotide isolates was achieved by injecting 2 µL of prepared sample onto the column and eluting using the following linear gradient: (A) 20 mM ammonium bicarbonate in water, pH 9.6, and (B) acetonitrile; 90% B for 0.25 minutes, followed by a linear gradient to 55% B at 4 minutes, sustained until 6 minutes. The column was re-equilibrated for 2.50 minutes at 90% B.
Detection was performed in positive ionization mode using a heated electrospray ionization source (HESI) under the following parameters: spray voltage of 3.5 kV; sheath and auxiliary gas flow rate of 40 and 20 arbitrary units, respectively; sweep gas flow rate of 2 arbitrary units; capillary temperature of 275 °C; auxiliary gas heater temperature of 350°C. Profile MS1 spectra were acquired with the following settings; mass resolution of 35,000, AGC volume of 1x106, maximum IT of 75 ms, with a scan range of 475 to 1050 m/z to include z=1 and z=2 ions of cyclic trinucleotides. Data dependent MS/MS spectra acquisition was performed using collision-induced dissociation (CID) with the following settings: mass resolution of 17,500; AGC volume of 1x105; maximum IT of 50 ms; a loop count of 5; isolation window of 1.0 m/z; normalized collision energy of 25 eV; dynamic exclusion was not used. Data reported is for the z=1 acquisition for each indicated cyclic trinucleotide.
Isothermal Titration Calorimetry
Isothermal titration calorimetry was performed at 20°C on a Microcal ITC 200 (Malvern Panalytical) in a buffer containing 20 mM Tris-HCl (pH 8.5), 200 mM NaCl, 5 mM MgCl2, 1 mM EDTA, and 1 mM TCEP. Nucleotides at 1 mM were injected into an analysis cell containing 100 µM Ec NucC (Fig. S3A-G, Table S2) . A second round of ITC was performed with 5¢pApA and 3¢,3¢ c-di-AMP in a buffer containing 10 mM Tris-HCl (pH 7.5), 25 mM NaCl, 10 mM MgCl2, and 1 mM TCEP ( Fig.  S3H-K, Table S3 ).
Crystallization and structure determination
E. coli NucC
We obtained crystals of E. coli NucC in the Apo state in hanging drop format by mixing protein (8-10 mg/mL) in crystallization buffer 1:1 with well solution containing 27% PEG 400, 400 mM MgCl2, and 100 mM HEPES pH 7.5 (plus 1 mM TCEP for selenomethionine-derivatized protein). For cryoprotection, we supplemented PEG 400 to 30%, then flash-froze crystals in liquid nitrogen and collected diffraction data on beamline 14-1 at the Stanford Synchrotron Radiation Lightsource (support statement below). We processed all datasets with the SSRL autoxds script, which uses XDS (Kabsch, 2010) for data indexing and reduction, AIMLESS (Evans and Murshudov, 2013) for scaling, and TRUNCATE (Evans, 2006) for conversion to structure factors. We determined the structure by single-wavelength anomalous diffraction methods with a 1.82 Å resolution dataset from selenomethionederivatized protein. We identified heavy-atom sites using hkl2map (Pape et al., 2004) (implementing SHELXC and SHELXD (Sheldrick, 2010) ), then provided those sites to the PHENIX Autosol wizard (Terwilliger et al., 2009) , which uses PHASER (McCoy et al., 2007) for phase calculation and RESOLVE for density modification (Terwilliger, 2003a) and automated model building (Terwilliger, 2003b) . We manually rebuilt the model in COOT (Emsley et al., 2010) , followed by refinement in phenix.refine (Afonine et al., 2012) using positional, individual B-factor, and TLS refinement (statistics in Table S1 ).
We obtained crystals of E. coli NucC bound to 5¢-pApA or cAAA in hanging drop format by mixing protein (8-10 mg/mL) in crystallization buffer plus 0.1 mM 5¢-pApA (Invivogen) or cAAA 1:1 with well solution containing 17-24% PEG 3350, 0.1 M Na/K tartrate, and 25 mM Tris-HCl pH 8.0. For cryoprotection, we added 10% glycerol, then flash-froze crystals in liquid nitrogen and collected diffraction data on beamline 24ID-E at the Advanced Photon Source at Argonne National Lab (support statement below). We processed datasets with the RAPD dataprocessing pipeline, which uses XDS, AIMLESS, and TRUNCATE as above. We determined the structures by molecular replacement using the structure of Apo NucC, manually rebuilt the model in COOT, and refined in phenix.refine using positional, individual B-factor, and TLS refinement (statistics in Table S1 ). For both 5¢-pApA and cAAA, ligands were fully built and assigned an occupancy of 0.33 to account for their location on a three-fold crystallographic rotation axis. The ligands were assigned a "custom-nonbonded-symmetry-exclusion" in phenix.refine to allow symmetry overlaps during refinement.
P. aeruginosa NucC
We obtained crystals of P. aeruginosa ATCC27853 NucC bound to cAAA by mixing protein (12 mg/mL) in cerystallization buffer plus 0.1 mM cAAA 1:1 with well solution containing 0.1 M CHES pH 9.9, 0.2 M ammonium acetate, and 20% PEG 3350. Crystals were cryoprotected with an additional 10% PEG 400, flash-frozen in liquid nitrogen, and a 2.6 Å diffraction dataset was collected at beamline 24ID-E at the Advanced Photon Source. We manually processed the dataset with XDS and TRUNCATE, and determined the structure by molecular replacement in PHASER using the structure of cAAA-bound Ec NucC as a search model. We manually rebuilt the model in COOT, and refined in phenix.refine using positional, individual B-factor, and TLS refinement (statistics in Table S1 ). 
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Nuclease assays
For all nuclease assays, UC Berkeley Macrolab plasmid 2AT (Addgene #29665; 4,731 bp; sequence in Supplemental Information) was used. Ec NucC (10 nM unless otherwise indicated) and second messenger molecules (10 nM unless otherwise indicated) were mixed with 1 µg plasmid DNA in a buffer containing 10 mM Tris-HCl (pH 7.5), 25 mM NaCl, 10 mM MgCl2, and 1 mM DTT (50 µL reaction volume), incubated 10 min at 37°C, then separated on a 1.2% agarose gel. Gels were stained with ethidium bromide and imaged by UV illumination.
High-throughput sequencing and data analysis
For high-throughput analysis of NucC products, 1 µg of vector 2AT was digested to completion by Ec NucC, separated by agarose gel, then the prominent ~50 bp band was removed from the gel and gel-purified (Qiagen Minelute). 80 ng of purified DNA was prepared for sequencing using the Swift Biosciences Accel-NGS 1S Plus DNA Library kit, then sequenced on an Illumina HiSeq 4000 (paired-end, 100 base reads), yielding ~402 million read pairs. The Accel-NGS 1S kit: (1) separates DNA fragments into single strands; (2) ligates the Adapter 1 oligo to the 3¢ end of the single-stranded fragment using an "adaptase" step that adds ~8 bp of low-complexity sequence to the fragment before adapter ligation; (3) ligates the Adapter 2 oligo to the 5¢ end of the original fragment. After sequencing, read 1 (R1) represents the 5¢ end of the original fragment, and read 2 (r2) represents the 3¢ end (preceded by ~ 8 bp of low-complexity sequence resulting from the adaptase step).
For NucC fragment length analysis, we took advantage of the fact that most NucC products are less than 100 base pairs in length. We identified the (reverse complement of the) 3¢ end of Adapter 1 (full sequence: 5¢ AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACAC GACGCTCTTCCGATCT 3¢) in R1, searching for the sequence "AGATCGGA". We calculated the length of each NucC fragment as: (length of R1 prior to AGATCGGA) minus 8 (average length of adaptase-added low-complexity sequence). The graph in Fig. 4C represents the lengths of 343 million NucC fragments.
For NucC cleavage site identification (Fig. 4B) , we truncated a 1-million read subset of R1 to 15 bases, then mapped to the 2AT plasmid sequence (with ends lengthened by 100 bases to account for circularity of the plasmid) using bowtie (Langmead et al., 2009) with the command: "bowtie -a -n 0 -m 3 -best -t". Of the successfully-mapped reads (594,183 of 1 million, 59.4%), 288,609 reads mapped to the forward strand and 305,574 mapped to the reverse strand. We extracted 20 bp of sequence surrounding each mapped 5¢ end (first base of R1), and input the resulting alignment of 594,183 sequences into WebLogo 3 (http://weblogo.threeplusone.com) (Crooks et al., 2004) . Conceptualization, RKL, QY, KDC; Methodology, RKL, QY, LP, ITM,  JDW, ATW, BL, MJ, PJK, KDC; Investigation, RKL, QY, LP, KRB Fig. S1C for comparison with the active site of SgrAI, and Fig. S1E for NucC sequence alignment). (D) Plasmid digestion assay with wild-type and active-site mutant D73N Ec NucC (10 nM), in the presence of cAAA (500 nM). "L" denotes linear plasmid, "SC" denotes closed-circular supercoiled plasmid, and "cut" denotes fully-digested DNA. for Ec NucC after pre-incubation with cAAA. While untreated Ec NucC shows a single peak corresponding to a homotrimer (Fig. S1A) , cAAA treatment results in the appearance of a second peak corresponding to a homohexamer (calculated MW 160.3 kDa). (F) Plasmid digestion assay with wild-type and structure-based mutants of Ec NucC (10 nM) in the presence and absence of cAAA (100 nM). . (B) Model of a NucC hexamer bound to DNA, assembled from separately overlaying the NucC monomers colored violet and blue with a structure of SgrAI bound to DNA (PDB ID 3DW9; ). The two modelled DNAs can be joined by a bent-two base-pair linker (dotted lines) to generate a contiguous dsDNA (two strands colored gray and orange). Cleavage of the scissile phosphates (spheres) at each active site would generate a double-strand break with a two-base 3¢ overhang. (C) Plasmid cleavage by Ec NucC in limiting Mg 2+ . Supercoiled DNA (SC) is converted to both nicked (N) and linear (L) forms, demonstrating significant doublestrand cleavage. (D) Analysis of NucC DNA cleavage site preference, from mapping ~600,000 cleavage sites from fully-digested plasmid DNA. Light-blue indicates the sequenced strand; the two-fold symmetry of the cleavage site supports a model of doublestrand cleavage resulting in two-base 3¢ overhangs. . Bound DNA, which coordinates one Mn 2+ ion with D188 and the main-chain carbonyl group of F241, is not shown. Inset shows active-site consensus motif. (E) Sequence alignment of E. coli MS115-1 (Ec) and P. aeruginosa ATCC27853 (Pa) NucC with four NucC homologs associated with Type IIIB CRISPR systems ( Fig. 4 ; all sequences in Table S4 ). Secondary structure shown is that of Ec NucC, with elements of the core nuclease fold in violet and embellishments in gray (Fig. 1B) . Orange highlights indicate the active-site consensus motif (IDx30EAK) and yellow highlights indicate the gate loop latch residues H136 and Y141. Green and cyan underlines indicate residues involved in the two interfaces that mediate NucC trimer assembly, calculated by PISA (Krissinel and Henrick, 2007) .
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Figure S2. Cyclic trinucleotide synthesis by Enterobacter cloacae CdnD02
(A) Mono-Q ion-exchange chromatography elution profile of reaction products generated by Enterobacter cloacae CdnD02 when supplied with GTP and ATP. The most prominent peak (cAAG) was previously characterized by NMR . The cAAG peak was verified, and two minor products identified as cAAA and cAGG, by LC-MS/MS mass spectrometry (panels B-D). (B-D) Mass fragmentation pattern of Mono-Q peak 1 (cAAA, panel B), peak 2 (cAAG , panel C), and peak 3 (cAGG, panel D). Roman numerals indicate associated bond cleavage, with asterisk ( * ) indicating additional loss of water. "-A", "-G", and "-P" indicate loss of adenine, guanine, and phosphate, respectively. 
Supplemental Note
Sequence of UC Berkeley Macrolab plasmid 2AT (Addgene #29665), used for NucC plasmid digestion assays and high-throughput sequencing: TTCTTGAAGACGAAAGGGCCTCGTGATACGCCTATTTTTATAGGTTAATGTCATGATAATAATGGTTTCTTAGACGTCAGGTGGCACTTTTCGG  GGAAATGTGCGCGGAACCCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAAT  AACATTGAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCC  AGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAAGATCCTTGAG  AGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTGTTGACGCCGGGCAAGAGC  AACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGA  ATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTG  CACAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTG  CAGCAATGGCAACAACGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAA  AGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATT  GCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCG  CTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAAGTTTACTCATATATACTTTAGATTGATTTAAAACTTCATTTTTAATT  TAAAAGGATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAA  AAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGC  CGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCCGTAGTTAGG  CCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTT  ACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGA  CCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAG  GGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGT  CGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTG  CTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAACGAC  CGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCTGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATATAT  GGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGTATACACTCCGCTATCGCTACGTGACTGGGTCATGGCTGCGCCCCGA  CACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGT  GTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCTGCGGTAAAGCTCATCAGCGTGGTCGTGAAGCGATTCACAGATGTCTGCCTG  TTCATCCGCGTCCAGCTCGTTGAGTTTCTCCAGAAGCGTTAATGTCTGGCTTCTGATAAAGCGGGCCATGTTAAGGGCGGTTTTTTCCTGTTTG  GTCACTGATGCCTCCGTGTAAGGGGGATTTCTGTTCATGGGGGTAATGATACCGATGAAACGAGAGAGGATGCTCACGATACGGGTTACTGATG  ATGAACATGCCCGGTTACTGGAACGTTGTGAGGGTAAACAACTGGCGGTATGGATGCGGCGGGACCAGAGAAAAATCACTCAGGGTCAATGCCA  GCGCTTCGTTAATACAGATGTAGGTGTTCCACAGGGTAGCCAGCAGCATCCTGCGATGCAGATCCGGAACATAATGGTGCAGGGCGCTGACTTC  CGCGTTTCCAGACTTTACGAAACACGGAAACCGAAGACCATTCATGTTGTTGCTCAGGTCGCAGACGTTTTGCAGCAGCAGTCGCTTCACGTTC  GCTCGCGTATCGGTGATTCATTCTGCTAACCAGTAAGGCAACCCCGCCAGCCTAGCCGGGTCCTCAACGACAGGAGCACGATCATGCGCACCCG  TGGCCAGGACCCAACGCTGCCCGAGATGCGCCGCGTGCGGCTGCTGGAGATGGCGGACGCGATGGATATGTTCTGCCAAGGGTTGGTTTGCGCA  TTCACAGTTCTCCGCAAGAATTGATTGGCTCCAATTCTTGGAGTGGTGAATCCGTTAGCGAGGTGCCGCCGGCTTCCATTCAGGTCGAGGTGGC  CCGGCTCCATGCACCGCGACGCAACGCGGGGAGGCAGACAAGGTATAGGGCGGCGCCTACAATCCATGCCAACCCGTTCCATGTGCTCGCCGAG  GCGGCATAAATCGCCGTGACGATCAGCGGTCCAGTGATCGAAGTTAGGCTGGTAAGAGCCGCGAGCGATCCTTGAAGCTGTCCCTGATGGTCGT  CATCTACCTGCCTGGACAGCATGGCCTGCAACGCGGGCATCCCGATGCCGCCGGAAGCGAGAAGAATCATAATGGGGAAGGCCATCCAGCCTCG  CGTCGCGAACGCCAGCAAGACGTAGCCCAGCGCGTCGGCCGCCATGCCGGCGATAATGGCCTGCTTCTCGCCGAAACGTTTGGTGGCGGGACCA  GTGACGAAGGCTTGAGCGAGGGCGTGCAAGATTCCGAATACCGCAAGCGACAGGCCGATCATCGTCGCGCTCCAGCGAAAGCGGTCCTCGCCGA  AAATGACCCAGAGCGCTGCCGGCACCTGTCCTACGAGTTGCATGATAAAGAAGACAGTCATAAGTGCGGCGACGATAGTCATGCCCCGCGCCCA  CCGGAAGGAGCTGACTGGGTTGAAGGCTCTCAAGGGCATCGGTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCCCAGTAGTAGG  TTGAGGCCGTTGAGCACCGCCGCCGCAAGGAATGGTGCATGCAAGGAGATGGCGCCCAACAGTCCCCCGGCCACGGGGCCTGCCACCATACCCA  CGCCGAAACAAGCGCTCATGAGCCCGAAGTGGCGAGCCCGATCTTCCCCATCGGTGATGTCGGCGATATAGGCGCCAGCAACCGCACCTGTGGC  GCCGGTGATGCCGGCCACGATGCGTCCGGCGTAGAGGATCGAGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGAGACCACAACGGT  TTCCCTCTAGTGCCGGCTCCGGAGAGCTCTTTAATTAAGCGGCCGCCCTGCAGGACTCGAGTTCTAGAAATAATTTTGTTTAACTTTAAGAAGG  AGATATAGATATCCCAACTCCATAAGGATCCGCGATCGCGGCGCGCCACCTGGTGGCCGGCCGGTACCACGCGTGCGCGCTGATCCGGCTGCTA  ACAAAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTT  TTTGCTGAAAGGAGGAACTATATCCGGACATCCACAGGACGGGTGTGGTCGCCATGATCGCGTAGTCGATAGTGGCTCCAAGTAGCGAAGCGAG  CAGGACTGGGCGGCGGCCAAAGCGGTCGGACAGTGCTCCGAGAACGGGTGCGCATAGAAATTGCATCAACGCATATAGCGCTAGCAGCACGCCA  TAGTGACTGGCGATGCTGTCGGAATGGACGACATCCCGCAAGAGGCCCGGCAGTACCGGCATAACCAAGCCTATGCCTACAGCATCCAGGGTGA CGGTGCCGAGGATGACGATGAGCGCATTGTTAGATTTCATACACGGTGCCTGACTGCGTTAGCAATTTAACTGTGATAAACTACCGCATTAAAG CTTATCGATGATAAGCTGTCAAACATGAGAA (a, b, c) Å 208.39, 208.39, 208.39 208.79, 208.79, 208.79 131.78, 131.78, 252.84 131.59, 131.59, 252.11 77.36, 132.87, 318.70 Multiplicity (last shell) 9.3 (7.2) 13.8 (9.5) 5.0 (4.9) 10.0 (9.3) 5.24 (4.69) 
